Pharmacogenomics is the study of how genes affect a person’s response to drugs. Because of each individual’s genes, a drug that works well for one person may not be as effective for another.
Pharmacogenomics — a pharmaceutically focused area of personalized medicine — ensures physicians are administering the right dosage of the right medicine at the right time to patients, resulting in safer and more effective drug treatment.
NorthShore’s Pharmacogenomics Clinic will allow the system to preemptively screen patients’ genetic makeup and integrate individualized clinical decision support alerts for medications into the system’s EMRs.
Through the clinic, patients are also able to speak with genetics counselors, pharmacogenomics-trained pharmacists and medical geneticists.
The Pharmacogenomics Clinic is part of the NorthShore’s Center for Medical Genetics, which is under the umbrella of the system’s Center for Personalized Medicine.
More articles on genomics:
Researchers to use ‘Internet of genomics’ to treat orphan diseases
National genome institute updates informed consent tool after Precision Medicine initiative
The promise of precision medicine: Care for the whole person
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.